100
Participants
Start Date
April 7, 2008
Primary Completion Date
February 4, 2009
Study Completion Date
February 4, 2009
CE-224,535
500 mg po BID
Placebo
no active ingredient
Complexo Hospitalario Universitario A Coruña, A Coruña
Hospital Nuestra Señora de La Esperanza, Santiago de Compostela
The Arthritis and Osteoporosis Center of Maryland, Frederick
Hospital General Universitario Gregorio Marañon, Madrid
Omega Research Consultants LLC, DeBary
Florida Arthritis Center, Lake Mary
Tampa Medical Group, PA, Tampa
New Horizons Clinical Research, Cincinnati
American Health Network, Avon
University Physicians, Columbia
University of Missouri-Columbia, Columbia
Best Clinical Trials, LLC (Administrative Only), New Orleans
George Stanley Walker, MD, New Orleans
Majid Abdul Jawad, MD, New Orleans
Arizona Arthritis & Rheumatology Associates, P.C., Mesa
Arthritis Center of Reno, Reno
Clínica Santa María, Sección Reumatología, Providencia
Arthritis Northwest, Spokane
Revmatologicka ambulance, Česká Lípa
Revmatologicky ustav, Prague
Revmatologicka ambulance, Prague
Investigadores Clinicos Asociados, México
Krakowskie Centrum Medyczne NZOZ, Krakow
Zaklad Reumatologii i Immunologii Klinicznej, Poznan
Oddzial Reumatologiczno-Rehabilitacyjny IIR Ortopedyczno-Rehabilitacyjny, Poznan
Inha University Hospital, Medicine/Rheumatology, Incheon
Pusan National University Hospital, Rheumatology, Internal Medicine, Pusan
Lead Sponsor
Pfizer
INDUSTRY